Fexofenadine

Generic Name
Fexofenadine
Brand Names
Allegra, Allegra-D, Mucinex Non-drowsy Allergy, Wal-fex, Telfast
Drug Type
Small Molecule
Chemical Formula
C32H39NO4
CAS Number
83799-24-0
Unique Ingredient Identifier
E6582LOH6V
Background

Fexofenadine is an over-the-counter second-generation antihistamine used in the treatment of various allergic symptoms. It is selective for the H receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier - this is in contrast to previous first-generation antihistamines, such as diphenhydramine, which readily bind to o...

Indication

In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients ≥2 years old and chronic idiopathic urticaria in patients ≥6 months old. In Canada, fexofenadine carries the same indications but is approved only for patients ≥12 years old. Fexofenadine is also available in combination with pseudoephedrine for the...

Associated Conditions
Allergic Rhinitis (AR), Chronic Idiopathic Urticaria, Seasonal Allergic Rhinitis
Associated Therapies
Antihistamine
pharmaphorum.com
·

France warns of penalties if Opella production goes offshore

Sanofi in exclusive talks with Clayton Dubilier & Rice to sell a 50% stake in Opella, valued at €16 billion. French government demands production, R&D, management, and workforce remain in France, with €70 million investment commitment. Sanctions include €40 million fine for closing facilities and €100,000 per layoff. France to take 2% stake in Opella. CD&R outbid PAI Partners, raising concerns over job security.
© Copyright 2024. All Rights Reserved by MedPath